Table 5.

Treatment characteristics of respondents with Crohn's disease and Ulcerative colitis.

Treatments	CD n (%)	UC n (%)	95% CI for difference (P value)
PO 5ASA	956 (54%)	672 (74%)	-23.7 to -16.4 (<0.001)
Topical Steroids/5ASA	183 (10%)	391 (43%)	-36.1 to -29.1 (<0.001)
PO Steroids	623 (35%)	259 (28%)	2.8 to 10.2 (0.001)
6 MP/Azathioprine	424 (24%)	109 (12%)	8.9 to 14.7 (<0.001)
IV Steroids	90 (5%)	41 (5%)	-1.1 to 2.2 (0.571)
Infliximab	99 (6%)	7 (1%)	3.6 to 6.0 (<0.001)

PO: Per os 5ASA: 5-Aminosalicylates 6MP: 6-Mercaptopurince IV: Intravenous